81 related articles for article (PubMed ID: 23116732)
1. In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy.
Mylonaki E; Manika K; Zarogoulidis P; Domvri K; Voutsas V; Zarogoulidis K; Mourelatos D
Mutat Res; 2012 Dec; 740(1-2):1-5. PubMed ID: 23116732
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic effects of recombinant interferon-gamma on lymphocytes cultures from patients with non-small cell lung cancer.
Baka S; Ekonomopoulou MT; Kosmidis C; Efthimiadis C; Iakovidou-Kritsi Z
Cancer Genet Cytogenet; 2009 Aug; 193(1):38-43. PubMed ID: 19602462
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic effects of multiagent chemotherapy on the peripheral lymphocytes of patients with small cell lung cancer.
Tominaga K; Shinkai T; Saijo N; Eguchi K; Sasaki Y; Sakurai M; Suga J; Nakajima T; Ochi H; Suemasu K
Jpn J Cancer Res; 1986 Dec; 77(12):1241-8. PubMed ID: 3029003
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Hum Exp Toxicol; 2007 May; 26(5):391-9. PubMed ID: 17623763
[TBL] [Abstract][Full Text] [Related]
5. Serial measurement of sister chromatid exchanges in the peripheral lymphocytes of patients with lung cancer receiving chemotherapy in relation to bone marrow toxicity.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Kojima A; Nakagawa K; Minato K; Nakajima T
Jpn J Cancer Res; 1989 Aug; 80(8):783-6. PubMed ID: 2555320
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
Izycki T; Chyczewska E; Naumnik W; Talalaj J; Panek B; Ossolinska M
Exp Oncol; 2004 Dec; 26(4):316-9. PubMed ID: 15627066
[TBL] [Abstract][Full Text] [Related]
8. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
[TBL] [Abstract][Full Text] [Related]
10. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
[TBL] [Abstract][Full Text] [Related]
11. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
12. [Recent topics in chemotherapy for elderly patients with lung cancer].
Okamoto H; Watanabe K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation.
Murakami S; Oshita F; Sugiura M; Kondo T; Saito H; Yamada K
Cancer Chemother Pharmacol; 2013 Mar; 71(3):705-11. PubMed ID: 23328865
[TBL] [Abstract][Full Text] [Related]
14. [Recent progress in chemotherapy for advanced lung cancer].
Negoro S; Fukuoka M
Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapy.
Matsumoto Y; Oka M; Sakamoto A; Narasaki F; Fukuda M; Takatani H; Terashi K; Ikeda K; Tsurutani J; Nagashima S; Soda H; Kohno S
Anticancer Res; 1997; 17(5B):3777-80. PubMed ID: 9427779
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy for lung cancer].
Fujiwara K; Eguchi K
Nihon Rinsho; 2000 May; 58(5):1087-92. PubMed ID: 10824554
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic effects of valproic acid and ziprasidone in human lymphocyte cultures.
Karapidaki I; Ekonomopoulou MT; Akritopoulou K; Anestakis D; Iakovidou-Kritsi Z
Neuropsychobiology; 2011; 64(4):219-23. PubMed ID: 21912190
[TBL] [Abstract][Full Text] [Related]
18. [Observation on sister chromatid exchange (SCE) in patients with lung cancer].
Liu SJ
Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):91-3. PubMed ID: 2988896
[No Abstract] [Full Text] [Related]
19. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
Shaw GL; Gazdar AF; Phelps R; Linnoila RI; Ihde DC; Johnson BE; Oie HK; Pass HI; Steinberg SM; Ghosh BC
Cancer Res; 1993 Nov; 53(21):5181-7. PubMed ID: 8221655
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A
Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
